CNMI acquires 60,000 Covid-19 test kits; receives first 20,000
Saipan-- The CNMI government reported two new Covid-19 cases Tuesday, bringing to 13 the total number of cases in the commonwealth. The number is anticipated to further increase as the CNMI builds its capability for mass testing with the arrival of the first 20,000 test kits the local government ordered from South Korea.
Both new patients are male--55 and 61. They are in stable condition and are being closely monitored by medical teams at Commonwealth Health Corp. medical teams, according the CNMI government.
"These cases are suggestive of community transmission within a cluster of linked cases, " states a press release from the CNMI government.
"CHCC has already initiated contact tracing for the most immediate contacts (close family members, friends, and associates) of these confirmed cases," officials said. "To ensure community transmission is limited, CHCC will expand contact tracing efforts."
CHCC and the Governor’s Covid-19 Task Force are working to expand designated isolation areas to closely monitor the condition of individuals with symptoms.
"As of April 14, 2020, the CNMI has submitted 59 specimens for Covid-19 testing. Of these 59 specimens, 55 have been processed, resulting in 13 positive specimens, 42 negative specimens. CHCC awaits the results of four specimens," officials said.
The CNMI is set to receive a total of 60,000 test kits within the next week and will soon be able to conduct on-island Covid-19 testing based on testing strategy guidelines from the U.S. Department of Health and Human Services.
“We have been working on getting these test kits here for the last three weeks, and we are glad to have the first 20,000 here on Saipan We have an additional 40,000 coming in this week to bring our total number to about 60,000 testing kits. CHCC will be working on getting these test kits ready to begin testing by the end of this week or early next week,” CNMI Gov. Ralph Torres said.
The Governor’s COVID-19 Task Force coordinated the delivery via direct charter flight from South Korea to Saipan. Along with the test kits, a clinical pathologist from South Korea also arrived on island to perform equipment calibration and to test quality assurance and quality control of the test kits.
“I want to thank our CHCC CEO Esther Muña for her leadership, as well as our Task Force Chairman Warren Villagomez, our Governor’s Authorized Representative Patrick Guerrero, Senate President Victor B. Hocog, Speaker Blas Jonathan T. Attao, and the Legislature leadership for assisting us in getting this done,” the governor added.
Since the increase in Covid-19 cases within the Pacific, the Governor’s COVID-19 Task Force and CHCC have been working tirelessly toward a laboratory testing strategy, which will not only provide on-island strategic testing capabilities, but also ensure that these testing strategies are sustainable within the CNMI by CHCC’s credentialed laboratory staff.
“I would like the public to know that there are several testing methodologies: point of care and laboratory-based testing,” said CHCC CEO Muña.
“Currently COVID-19 testing technologies are all laboratory-based PCR, which requires an environment that maintains appropriate quality controls to reduce any false positive or false negative results,” she noted. PCR stands for Polymerase Chain Reaction. It is a fast and inexpensive technique to amplify small segments of DNA so they can be used to detect viruses such as COVID-19 in a short time frame.
The 20,000 test kits that arrived last night are the DiaPlexQ (PCR) Novel Coronavirus Detection Kit from SolGent in South Korea. SolGent recently shipped 150,000 of these test kits to the United States over the weekend.
Approximately 750,000 Covid-19 test kits from South Korea are being delivered to the United States.
Torres and CNMI leadership have been cognizant of South Korea’s decline in new cases due to their early testing efforts to “flatten the curve.” Torres then pushed forward plans to purchase the test kits for the CNMI three weeks ago.
Since the Governor’s Public Health Emergency declaration, CHCC has been scaling up its testing capabilities to include the following laboratory-based testing platforms:
• GeneXpert
• BioFire
• ABI 7500 Fast Dx
• Abbott ID Now
• DiaPlexQ (PCR)
“These options are available now as a result of significant technological advances in laboratory science over the last three decades, resulting in small populations being able to benefit from highly complex testing. This was not the case years ago when jurisdictions like the CNMI with only a population of 55,000 needed to send our specimens off island to Honolulu or San Francisco, where larger populations allowed for efficient use of very large and complex testing platforms,” said CEO Muña.
The Governor’s Task Force and CHCC are finalizing a CNMI testing implementation plan based on the HHS strategy listed below:
• Hospitalized patients and healthcare facility workers with symptoms Priority
• Patients in long-term care facilities with symptom
• Patients 65 years of age or older with symptoms
• Patients with underlying conditions with symptoms
• First responders with symptoms Priority
• Critical infrastructure workers with symptoms
• Individuals who do not meet any of the above categories with symptoms
• Healthcare facility workers and first responders
• Individuals with mild symptoms in communities experiencing high numbers of COVID19 hospitalizations
Torres noted that the overall prioritization of testing will be determined by CHCC, but particular priority will be given to hospitalized patients, persons under investigation, healthcare workers, man’amko, and frontline first responders. “To the great people of the Commonwealth, I want to thank you all for your patience and we are working extremely hard to get as many people tested as possible. Our goal since Day One is to test everybody. It is going to take some time, but we are definitely moving in that direction,” Torres said.